v3.25.4

Capital Stock (Tables)

12 Months Ended

Sep. 30, 2025

Capital Stock [Abstract]

Schedule of Black-Scholes Option Valuation Model, with the Following Weighted Average Assumptions

The fair values of these stock options were estimated at the dates of grant, which is August 6, 2025 for stock options granted in fiscal 2025 and October 19, 2023 for stock options granted in fiscal 2024, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:

		September 30, 2025				September 30, 2024
Stock price		$	0.54			$	1.16
Exercise price		$	0.54			$	1.16
Expected risk free interest rate			3.77	%			4.75	%
Expected volatility			136.90	%			166.40	%
Expected life in years			5				5
Expected dividend yield			nil				nil
Grant date fair value per option		$	0.48			$	1.10

Schedule of Outstanding Stock Options

A continuity schedule of outstanding stock options at September 30, and the changes during the periods, is as follows:

		Number of Stock Options				Weighted Average Exercise Price
						US$
Balance, September 30, 2023			455,000				3.73
Granted			1,030,000				1.16
Exercised			-				-
Forfeited			-				-
Balance, September 30, 2024			1,485,000				1.95
Granted			1,030,000				0.54
Exercised			-				-
Forfeited			-				-
Balance, September 30, 2025			2,515,000				1.37

Schedule of Outstanding Unvested Stock Options

A continuity schedule of outstanding unvested stock options at September 30, and the changes during the periods, is as follows:

		Number of Unvested Stock Options				Weighted Average Grant Date Fair Value
						US$
Balance, September 30, 2023			22,500				2.11
Granted			1,030,000				1.10
Vested			(775,000	)			1.19
Forfeited			-				-
Balance, September 30, 2024			277,500				1.10
Granted			1,030,000				0.48
Vested			(1,161,250	)			0.68
Forfeited			-				-
Balance, September 30, 2025			146,250				0.61

Schedule of Stock Options Outstanding and Exercisable

A summary of stock options outstanding and exercisable at September 30, 2025:

		Exercisable				Weighted Average Exercise Price				Weighted Average Remaining Contractual Life (Years)
						US$
Grant date
November 1, 2021			365,000				4.10				6.08
December 30, 2022			90,000				2.21				7.25
October 19, 2023			1,013,750				1.16				8.08
August 6, 2025			900,000				0.54				9.83

A summary of warrants outstandingand exercisable at September 30, 2025:

		Exercisable				Weighted Average Exercise Price				Weighted Average Remaining Contractual Life (Years)
						US$
Grant date
March 29, 2021			1,562,686				7.50				0.49
January 8, 2024			400,000				2.00				3.27
May 27, 2025			13,500,000				0.48				0.65
August 26, 2025			253,425				0.73				4.90

Schedule of Stock-Based Compensation Expense

A summary of stock-based compensation expense for the years ended September 30 2025, 2024 and 2023 is as follows:

		September 30,				September 30,				September 30,
		2025				2024				2023
		US$				US$				US$
Common share awards			524,280				834,399				1,796,179
Stock option awards			448,599				1,142,787				265,631
Total			972,879				1,977,186				2,061,810

Schedule of Warrants

The continuity of the Company’s warrants is as follows:

		Number of Warrants				Weighted Average Exercise Price
						US$
Balance, September 30, 2023			1,562,686				7.50
Granted			400,000				2.00
Exercised			-				-
Forfeited			-				-
Balance, September 30, 2024			1,962,686				6.38
Granted			13,753,425				0.48
Exercised			-				-
Forfeited			-				-
Balance, September 30, 2025			15,716,111				1.22

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration